Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2
- PMID: 10369850
- DOI: 10.1056/NEJM199906173402404
Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2
Abstract
Background: The detection of pheochromocytomas in patients at risk for these tumors, such as patients with von Hippel-Lindau disease or multiple endocrine neoplasia type 2 (MEN-2), is hindered by the inadequate sensitivity of commonly available biochemical tests. In this study we evaluated measurements of plasma normetanephrine and metanephrine for detecting pheochromocytomas in patients with von Hippel-Lindau disease or MEN-2.
Methods: We studied 26 patients with von Hippel-Lindau disease and 9 patients with MEN-2 who had histologically verified pheochromocytomas and 50 patients with von Hippel-Lindau disease or MEN-2 who had no radiologic evidence of pheochromocytoma. Von Hippel-Lindau disease and MEN-2 were diagnosed on the basis of germ-line mutations of the appropriate genes. The plasma concentrations of normetanephrine and metanephrine were compared with the plasma concentrations of catecholamines (norepinephrine and epinephrine) and urinary excretion of catecholamines, metanephrines, and vanillylmandelic acid.
Results: The sensitivity of measurements of plasma normetanephrine and metanephrine for the detection of tumors was 97 percent, whereas the other biochemical tests had a sensitivity of only 47 to 74 percent. All patients with MEN-2 had high plasma concentrations of metanephrine, whereas the patients with von Hippel-Lindau disease had almost exclusively high plasma concentrations of only normetanephrine. One patient with von Hippel-Lindau disease had a normal plasma normetanephrine concentration; this patient had a very small adrenal tumor (<1 cm). The high sensitivity of measurements of plasma normetanephrine and metanephrine was accompanied by a high level of specificity (96 percent).
Conclusions: Measurements of plasma normetanephrine and metanephrine are useful in screening for pheochromocytomas in patients with a familial predisposition to these tumors.
Similar articles
-
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.N Engl J Med. 1993 Nov 18;329(21):1531-8. doi: 10.1056/NEJM199311183292103. N Engl J Med. 1993. PMID: 8105382
-
How to detect pheochromocytomas?--the diagnostic relevance of plasma free metanephrines.Wien Klin Wochenschr. 2002 Apr 15;114(7):246-51. Wien Klin Wochenschr. 2002. PMID: 12089859
-
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.J Clin Endocrinol Metab. 2001 May;86(5):1999-2008. doi: 10.1210/jcem.86.5.7496. J Clin Endocrinol Metab. 2001. PMID: 11344198
-
Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour.J Intern Med. 2005 Jan;257(1):60-8. doi: 10.1111/j.1365-2796.2004.01425.x. J Intern Med. 2005. PMID: 15606377 Review.
-
Diagnosis and management of tumors of the adrenal medulla.Horm Metab Res. 2005 Dec;37(12):717-21. doi: 10.1055/s-2005-921091. Horm Metab Res. 2005. PMID: 16372223 Review.
Cited by
-
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.Nat Rev Endocrinol. 2024 Aug 15. doi: 10.1038/s41574-024-01024-5. Online ahead of print. Nat Rev Endocrinol. 2024. PMID: 39147856 Review.
-
The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.Int Braz J Urol. 2023 May-Jun;49(3):307-319. doi: 10.1590/S1677-5538.IBJU.2023.0038. Int Braz J Urol. 2023. PMID: 37115176 Free PMC article. Review.
-
Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer.Cell Rep. 2022 Aug 16;40(7):111218. doi: 10.1016/j.celrep.2022.111218. Cell Rep. 2022. PMID: 35977518 Free PMC article.
-
Serotonin limits generation of chromaffin cells during adrenal organ development.Nat Commun. 2022 May 25;13(1):2901. doi: 10.1038/s41467-022-30438-w. Nat Commun. 2022. PMID: 35614045 Free PMC article.
-
Personalized Management of Pheochromocytoma and Paraganglioma.Endocr Rev. 2022 Mar 9;43(2):199-239. doi: 10.1210/endrev/bnab019. Endocr Rev. 2022. PMID: 34147030 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical